MedTrace Logo

Developing a Model to Better Predict Diabetes and/or Risk of Developing Diabetes

NCT04905485 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2912

Last updated 2021-06-08

No results posted yet for this study

Summary

Participants who were previously Viome costumers who signed informed consent to participate and self reported type 2 diabetes or pre-diabetes were enrolled. They provided stool samples to VIOME and were provided with precision diet and supplement recommendations. The information obtained from this study is used to train a model to predict diabetes and/or risks of developing diabetes.

Conditions

Interventions

BEHAVIORAL

VIOME Precision Nutrition Program

Precision diet and supplement recommendations based on participants' microbiome results.

Sponsors & Collaborators

  • Viome

    lead INDUSTRY

Principal Investigators

  • Guruduth Banavar, PhD · Viome

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-21
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04905485 on ClinicalTrials.gov